Le Lézard
Classified in: Health
Subject: MAT

Renowned Facelift Surgeon, Dr. John M. Anastasatos, Introduces Innovative Endoscopic Percutaneous Facelift Procedure to Patients in Beverly Hills and Athens, Greece


Dr. John Anastasatos is a renowned plastic surgeon widely known for his expertise, in providing very natural-looking facelifts, rhinoplasty and breast augmentation outcomes. With offices in Beverly Hills and Athens Greece, Dr. Anastasatos serves a diverse group of patients' cosmetic surgery needs.

LOS ANGELES, July 20, 2023 /PRNewswire-PRWeb/ -- Dr. John M. Anastasatos, a highly esteemed plastic surgeon recognized as one of the Top 10 Cosmetic Surgery Clinics in the World by The Luxe Insider with offices in Beverly Hills and Athens, Greece, has proudly announced the introduction of an advanced cosmetic procedure known as the Endoscopic Percutaneous Facelift. This revolutionary technique offers patients a minimally invasive and highly effective solution for achieving youthful and natural-looking results.

The Endoscopic Percutaneous Facelift, developed by Dr. Anastasatos, combines cutting-edge technology and meticulous surgical expertise to address the signs of aging in a less invasive manner. This innovative procedure employs the use of a tiny camera called an endoscope, which allows for precise visualization and access to the underlying facial structures. By utilizing smaller incisions, patients can experience reduced scarring, faster recovery times, and enhance overall outcomes.

With his extensive experience and dedication to the art of facial rejuvenation, Dr. Anastasatos has gained recognition as a leading expert in the field. He has successfully treated numerous patients, helping them achieve their desired aesthetic goals and restore their youthful appearance. Dr. Anastasatos believes that each individual has unique facial characteristics and tailors his approach to creating natural-looking results that enhance the patient's own beauty.

"I am thrilled to introduce the Endoscopic Percutaneous Facelift to my patients in Beverly Hills and Athens," said Dr. Anastasatos. "This procedure represents a significant advancement in facial rejuvenation, allowing for remarkable results with minimal downtime. By utilizing state-of-the-art techniques, we can provide patients with a customized treatment plan that enhances their natural features, resulting in a refreshed and more youthful appearance."

The Endoscopic Percutaneous Facelift is suitable for patients seeking to address various concerns, including sagging skin, deep wrinkles, jowls, and loss of facial volume. By utilizing small incisions hidden within the hairline, Dr. Anastasatos can reposition and lift the underlying tissues, remove excess skin, and restore a more youthful contour to the face. The procedure is performed under local anesthesia with the option of sedation to ensure patient comfort.

Dr. John M. Anastasatos invites prospective patients to schedule a consultation at his Beverly Hills or Athens Greece office to explore the benefits of the Endoscopic Percutaneous Facelift. During the consultation, patients will receive a comprehensive evaluation, where Dr. Anastasatos will discuss their aesthetic goals and determine the most appropriate treatment plan.

About Dr. John M. Anastasatos:

Dr. John M. Anastasatos is a board-certified plastic surgeon with offices in Beverly Hills, California, and Athens, Greece. He is widely recognized for his expertise in facial rejuvenation, body contouring, and breast surgery. Dr. Anastasatos has a passion for helping his patients achieve their desired aesthetic goals by combining advanced surgical techniques with an artistic approach. With a commitment to delivering outstanding results, Dr. Anastasatos continues to innovate and refine his surgical techniques, ensuring the highest level of patient satisfaction.

Media Contact

John M Anastasatos, Los Angeles Plastic Surgery, (310) 888-4048, [email protected], https://www.losangelesplasticsurgery.com/

 

SOURCE Los Angeles Plastic Surgery


These press releases may also interest you

at 19:41
Celltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale acquisition cost (WAC). Adalimumab-aaty will be...

at 19:30
Rakuten Medical, Inc., a global...

at 18:44
Healthcare technology company RXNT, a leading developer of ambulatory clinical and practice management software, announced its successful transition to the Relay Exchange clearinghouse via Change Healthcare on May 9th, 2024. This...

at 18:32
Center for Lyme Action (CLA) and Generation Lyme are pleased to announce a new Community Partnership to leverage each nonprofit organization's distinct resources to support current and future Lyme disease advocates. This collaboration marks a...

at 18:18
LG Electronics announces the launch of the third season of its podcast, "Transparent Conversations," which brings conversations about mental health directly to college campuses around the country, with live tapings throughout the year at pivotal...

at 18:15
DaVita Inc.  today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at BofA Securities 2024 Health Care Conference on...



News published on and distributed by: